Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates: An international randomized phase III study in metastatic breast cancer. - Brufman,G.; Colajori,E.; Ghilezan,N. (Ann Oncol, 1997)